StratDeck

Two stocks in Biotechnology

Oxford Nanopore Technologies vs Oxford Biomedica: profit, growth, debt and price compared

Oxford Nanopore Technologies is stronger on 3 of 6 figures: sales growth, debt and price trend. Oxford Biomedica is stronger on 1: profit margin.

Figures as of 18 November 2026Yahoo Finance
Explore Oxford Nanopore Technologies' storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Oxford Nanopore Technologies and Oxford Biomedica side by side
Oxford Nanopore TechnologiesONT.LOxford BiomedicaOXB.L
Net margin−51.7%Stronger: −23.2%
Revenue growth, past yearStronger: +10.50%+9.00%
Debt to equityStronger: 9.9%273.1%
Forward P/ELossLoss
Dividend yield——
AnalystsBuy · 12Buy · 8
From its 200-day averageStronger: +22.8%−5.2%

Share price over the past year

  • Oxford Nanopore Technologies+58.4%
  • Oxford Biomedica−13.2%

20 Nov 202518 Nov 2026

Oxford Nanopore Technologies or Oxford Biomedica: which is stronger?

  • OXB.L

    Which is more profitable?

    Oxford Biomedica keeps more of each sale as profit: −23.2% against −51.7%.

  • ONT.L

    Which is growing its sales faster?

    Oxford Nanopore Technologies is growing its sales faster: +10.50% over the past year, against +9.00%.

  • ONT.L

    Which has borrowed less?

    Oxford Nanopore Technologies has borrowed less: its debt is 9.9% of what its shareholders own, against 273.1% for Oxford Biomedica.

  • Which costs less for the profit it is expected to make?

    Both are expected to make a loss over the next year.

  • Which pays more in dividends?

    Neither pays a dividend.

  • Which do analysts rate higher?

    Analysts rate both the same: Buy.

  • ONT.L

    Which is in the stronger price trend?

    Oxford Nanopore Technologies' price is in the stronger trend: 22.8% above its 200-day average, against 5.2% below.

What each company does

ONT.LOxford Nanopore Technologies

Oxford Nanopore Technologies plc researches, develops, manufactures, and commercializes DNA and RNA sequencing technology.

Reports results on 3 March 2027

OXB.LOxford Biomedica

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Reports results on 25 March 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every UK healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.